CASE STUDY: Real-Life AI in Clinical Supply Chain: What’s Working Right Now for EIKON 📊 LIVE POLL

  • How Eikon is deploying AI today across vendor oversight, demand planning, compliance documentation and stakeholder communication
  • Separating Real-World Value from the Hype: Discover what worked, what failed, and what the team would do differently, gaining a grounded perspective on where AI delivers genuine ROI versus where it falls short
  • Learn how practical AI tools are uncovering hidden logistics risks and driving operational efficiencies in ways traditional supply chain software simply cannot match

Biotechs and FDA’s “Real-Time Clinical Trials” program: Postpone the myth or prepare for reality?

This session will explore whether the FDA’s Real-Time Clinical Trials (RTCT) program is an aspirational vision for the future or a near-term reality that biotech companies should begin preparing for today. This session will discuss what sponsors can do now to position themselves for participation in this emerging real-time development model.

  • Separate hype from reality: Examine FDA’s stated goals for RTCTs, the scope of the pilot program, and its potential opportunities and limitations.
  • Understand the broad operational and technology requirements: Identify the critical capabilities needed for participation in the pilot program.
  • Develop your biotech readiness roadmap: Discuss practical actions sponsors can take today to assess their organizational readiness and engage with FDA as the RTCT model evolves.

When “Real Time” Is Already Too Late: Lessons from Biomarker Operations

  • What “real time” looked like from the sponsor side when site activity became visible only after the work was complete
  • How late queries and accessioning delays slowed data readout in a Phase I oncology study
  • What changed when issues were identified and corrected before shipment
  • Why clinical trial execution is foundational to better data and AI-ready trials